AXA (EPA:CS) Given a €27.50 Price Target by Goldman Sachs Group Analysts

Goldman Sachs Group set a €27.50 ($31.98) target price on AXA (EPA:CS) in a report released on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

Several other brokerages also recently issued reports on CS. HSBC cut their price objective on Canada Goose from C$62.00 to C$55.00 and set a buy rating for the company in a research report on Monday, June 3rd. JPMorgan Chase & Co. reiterated a buy rating on shares of Gilead Sciences in a research report on Tuesday, July 2nd. Barclays boosted their target price on Zimmer Biomet from $113.00 to $117.00 and gave the stock an underweight rating in a research report on Monday, April 15th. Royal Bank of Canada dropped their target price on Advance Auto Parts to $178.00 and set an outperform rating for the company in a research report on Tuesday, May 14th. Finally, UBS Group set a $125.00 target price on Caterpillar and gave the stock a sell rating in a research report on Friday, May 3rd. Four analysts have rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The stock has an average rating of Buy and an average target price of €26.56 ($30.89).

Shares of CS opened at €23.64 ($27.49) on Monday. The company has a fifty day simple moving average of €22.84. AXA has a 52-week low of €22.13 ($25.73) and a 52-week high of €27.69 ($32.20).

About AXA

AXA SA, through its subsidiaries, provides insurance and asset management services worldwide. It operates in seven segments: France, Europe, Asia, AXA XL, the United States, International, and Transversal & Central Holdings. The company offers a range of insurance products, including life and savings, property and casualty, and health.

Featured Article: Penny Stocks

Analyst Recommendations for AXA (EPA:CS)

Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.